Abstract
Serotonergic receptor binding is altered in the medullary serotonergic nuclei, including the paragigantocellularis lateralis (PGCL), in many infants who die of sudden infant death syndrome (SIDS). The PGCL receives inputs from many sites in the caudal brainstem and projects to the spinal cord and to more rostral areas important for arousal and vigilance. We have shown previously that local unilateral nonspecific neuronal inhibition in this region with GABAA agonists disrupts sleep architecture. We hypothesized that specifically inhibiting serotonergic activity in the PGCL would result in less sleep and heightened vigilance. We analyzed sleep before and after unilaterally dialyzing the 5-HT1A agonist (±)-8-hydroxy-2-(dipropylamino)-tetralin (8-OH-DPAT) into the juxtafacial PGCL in conscious newborn piglets. 8-OH-DPAT dialysis resulted in fragmented sleep with an increase in the number and a decrease in the duration of bouts of nonrapid eye movement (NREM) sleep and a marked decrease in amount of rapid eye movement (REM) sleep. After 8-OH-DPAT dialysis, there were decreases in body movements, including shivering, during NREM sleep; body temperature and heart rate also decreased. The effects of 8-OH-DPAT were blocked by local pretreatment with N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexane-carboxamide, a selective 5-HT1A antagonist. Destruction of serotonergic neurons with 5,7-DHT resulted in fragmented sleep and eliminated the effects of subsequent 8-OH-DPAT dialysis on REM but not the effects on body temperature or heart rate. We conclude that neurons expressing 5-HT1A autoreceptors in the juxtafacial PGCL are involved in regulating or modulating sleep. Abnormalities in the function of these neurons may alter sleep homeostasis and contribute to the etiology of SIDS.
Introduction
Sudden infant death syndrome (SIDS) remains the most common cause of death in postneonatal infancy. A major advance in our understanding of the etiology of SIDS has been the finding that many SIDS infants have decreased binding of muscarinic and kainate receptors in the arcuate nucleus at the ventral surface of the medulla (Kinney et al., 1995; Panigrahy et al., 1997) and abnormal binding to serotonergic (5-HT) receptors in the medullary serotonergic nuclei, including the paragigantocellularis lateralis (PGCL) (Panigrahy et al., 2000; Kinney et al., 2003). Dysfunction in these regions may increase the risk for SIDS by altering protective reflexes to stressors encountered during sleep such as hypercapnia, hypoxia, and laryngeal stimulation (Filiano and Kinney, 1994). In conscious animals, the local dialysis of GABAA agonists into the PGCL decreases the ventilatory response to hypercapnia (Curran et al., 2001) and prolongs the laryngeal chemoreflex (Van der Velde et al., 2003).
Sleep represents a period of relative vulnerability, when many control systems function at lower levels. Although SIDS presumably occurs during sleep, there is little evidence to support a specific sleep abnormality. Sleep research in SIDS has been focused on arousal as an important protective mechanism (Kahn et al., 2002). However, an increase in arousability may also be disadvantageous and lead to fragmented sleep or sleep deprivation (Simpson, 2001). We have reported previously that nonspecific neuronal inhibition with GABAA agonists in the PGCL region in the piglet disrupts sleep architecture and results in more wakefulness (WAKE) (Darnall et al., 2001).
The results of our previous experiments and the findings of altered serotonergic receptor binding in the PGCL in SIDS infants prompted us to look more closely at the role of PGCL 5-HT neurons in sleep. The PGCL extends caudally from the superior olive to the anterior pole of the lateral reticular nucleus (Andrezik et al., 1981). It receives inputs from the nucleus of the solitary tract, A1 region, parabrachial nucleus, Kölliker-Fuse nucleus, periaqueductal gray, and the hypothalamus. In addition, the more rostral (juxtafacial) PGCL receives polymodal sensory inputs from the inferior colliculus, the dorsal column nuclei, and the medial geniculate nucleus (Van Bockstaele et al., 1989, 1993; Van Bockstaele and Aston-Jones, 1995). The PGCL sends important projections to more rostral areas important for alertness and arousal, including the locus ceruleus (LC) (Aston-Jones et al., 1986, 1991a), and to both the dorsal and ventral horns of the spinal cord (Holstege and Kuypers, 1987) with extensive collateralization supplying multiple spinal cord segments (Bowker and Abbott, 1990; Kausz, 1991). Thus, neurons located in the PGCL are positioned to play an important role in integrating multiple sensory inputs for modulating brain and spinal alerting systems. In this study, we focused on 5-HT neurons in the juxtafacial PGCL and asked whether decreasing serotonergic activity would alter normal sleep patterns. Our paradigm was to evaluate sleep after unilaterally decreasing serotonergic activity in the PGCL using the selective 5-HT1A agonist (±)-8-hydroxy-2-(dipropylamino)-tetralin (8-OH-DPAT).
Materials and Methods
Experiments were performed on piglets of either sex, aged 4–18 d and weighing 1.5–3.8 kg at the time of study. All surgery and experimental protocols were approved by The Institutional Animal Care and Use Committee of Dartmouth College. When not in the laboratory, the piglets were housed with the sow and siblings in a farrowing crate located in the Dartmouth College Animal Resource Center and were provided with a constant temperature and 12 h light/dark cycle. Piglets were brought to the laboratory on 1 or more days before surgery to acclimatize them to the experimental environment.
Surgical instrumentation. Our surgical procedures have been described in detail previously (Curran et al., 2001; Darnall et al., 2001). Briefly, under sterile conditions and using isofluorane anesthesia, a dual-lumen catheter was placed through the femoral artery into the abdominal aorta, and a telemetric thermistor was placed subcutaneously just lateral to the abdominal midline. After placement in a stereotaxic apparatus, a microdialysis guide tube was placed through a burr hole in the skull using coordinates derived from a regression formula (Sun et al., 2000). An attempt was made to place the tip between the midline and the medial border of the facial nucleus near the ventral surface. EEG electrodes were screwed into the left frontal and right occipital regions of the skull and referenced to a right parietal electrode. Electro-oculogram (EOG) electrodes were sewn in place lateral to and one above and one below each eye. Bipolar EMG electrodes were sewn deep into the neck muscles. All wires from the electrodes were attached to brass contacts inserted into two plastic pedestals, fixed to the skull with the microdialysis guide tube with cement. The femoral catheter was tunneled through the skin and exited on the back. After surgery, the animals were provided with analgesia and antibiotics, allowed to recover, and returned to the sow and siblings in the animal care facility.
Measurements. The animals were first studied 24–48 h after surgery. The piglet was suspended in a sling inside a barometric plethysmograph (Drorbaugh and Fenn, 1955; Bartlett and Tenney, 1970) modified to allow continuous gas flow (Pappenheimer, 1977). Air flowing through the plethysmograph was heated (∼38°C) and fully humidified. The plethysmograph wall temperature was adjusted according to the weight and age of the animal using a circulating water bath to provide a thermoneutral environment. Heart rate (HR) and mean arterial pressure (BPm) were calculated from continuous measurements of arterial pressure (World Precision Instruments, Sarasota, FL). Respiratory measurements were derived from plethysmograph pressure fluctuations (Validyne, Northridge, CA). EEG, EOG, and EMG signals were amplified and bandpass filtered (0.1–300 Hz for EEG and EOG and 10–300 Hz for EMG). The fractional O2 content of inlet and outlet air (model S-3A/II; Applied Electrochemistry, Pittsburg, PA) and the fractional content of CO2 in the outlet air (Capstar-100; CWI, Ardmore, PA) were measured continuously to calculate oxygen consumption (VO2) and carbon dioxide production (VCO2). Plethysmograph air and animal core temperatures were continuously measured (YSI, Yellow Springs, OH and DSI, St. Paul, MN). All signals were digitized at 1000 Hz and recorded using a computerized data acquisition system (PowerLab; ADInstruments, Castle Hill, Australia). Throughout the experiment, piglet behavior was video recorded and digitized for later sleep scoring.
Protocols. Animals were studied for 1–10 d after surgery. Based on previous observations showing that young newborn piglets sleep in bouts throughout the 24 h period with little consolidation during the dark cycle, all studies were performed between 10:00 A.M. and 3:00 P.M. and were of similar recording duration. The plethysmograph was sealed ∼1.5 h before the experiment to allow the temperature and humidity to stabilize. Calibration was performed using sequential triplicate injections of 1, 2, 3, and 5 ml of air. The piglet was then placed in the plethysmograph and connected to the monitoring equipment. The microdialysis probe was inserted and dialysis started with artificial CSF (aCSF) [containing the following (in mm): 152.2 Na, 3.0 K, 131.1 Cl, and 1.5 Ca, adjusted to a pH of 7.4] at a flow rate of 8.5 μl/min. After temperature, humidity, [CO2], and [O2] reached stable values (∼1 h), measurements were begun. Two protocols were used in this study: (1) an experimental protocol in which normal sleep cycling was first recorded for ∼2 h, during which aCSF was continuously dialyzed. The dialysate was then switched to either 10 or 30 mm 8-OH-DPAT (Sigma, St. Louis, MO) and continued for 30 min. The dialysate was then switched back to aCSF for the remainder of the experiment; and (2) a time-control protocol in which aCSF was substituted for the period of 8-OH-DPAT dialysis resulting in continuous aCSF dialysis throughout the experiment.
To confirm that our results were secondary to activating 5-HT1A receptors, four animals were dialyzed for 30 min with 30 mm 8-OH-DPAT after pretreatment for 30 min of local dialysis with N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexane-carboxamide (WAY100635; Sigma), a selective, “silent” 5-HT1A-receptor antagonist. The term silent 5-HT1A-receptor antagonist has been used to distinguish true antagonists from partial agonists and describes compounds that lack intrinsic activity yet effectively block the effects of receptor agonists. To further determine whether our results were attributable to activating somato-dendritic 5-HT1A autoreceptors or postsynaptic 5-HT1A receptors, 5,7-dihydroxytryptamine (5,7-DHT; Sigma), a toxin selective for 5-HT neurons, was dialyzed into the PGCL of four animals after pretreatment with desipramine hydrochloride to prevent destruction of catecholaminergic neurons. After a week, 30 mm 8-OH-DPAT was dialyzed into the same region of the PGCL, and the results were compared with a group of animals of similar ages not treated with 5,7-DHT.
8-OH-DPAT doses. Relatively large doses of 8-OH-DPAT were used in the current study compared with those used in other dialysis experiments in the dorsal raphé (Portas et al., 1996). Keeping in mind that the estimated tissue concentration is of the dialysate concentration (De Lange et al., 1995), 10 mm 8-OH-DPAT (estimated 1 mm tissue concentration) produced some effects on sleep, but 30 mm was necessary to obtain consistent results. These doses are consistent with those used by other investigators in the caudal brainstem (Berner et al., 1999), and larger doses may be necessary for a number of reasons. Compared with dorsal raphé 5-HT neurons, caudal medullary 5-HT neurons have faster firing rates (Heym et al., 1982b), may have fewer 5-HT1A autoreceptors (Trulson and Frederickson, 1987), and appear to be less sensitive to 5-HT1A agonists (Heym et al., 1982a). Our fluorescein data and 5,7-DHT data, although not conclusive, provide some level of confidence that we were affecting 5-HT1A receptors in an area restricted to the juxtafacial PGCL and a portion of the retrotrapezoid nucleus.
Data reduction and calculations. Data reduction, including sleep scoring, was done using custom programs written in Matlab (MathWorks, Natick, MA). For sleep-state scoring, a wavelet-based analysis that has been described previously (Darnall et al., 2001) was used to derive frequency information from the EEG. Slow wave (δ) activity was estimated by combining levels 6–9 of a 9 level discrete wavelet decomposition/reconstruction (0.3–4.7 Hz), and theta activity was estimated by using level 5 (4.7–9.4 Hz). A similar analysis was done for EOG and nuchal EMG recordings to isolate the most important features of each signal. Periods of non-rapid eye movement (NREM) sleep, rapid eye movement (REM) sleep, and WAKE were identified using the combination of EEG, EOG, nuchal EMG data, and behavioral criteria. An automated sleep-scoring algorithm using criteria related to the changes in the delta and theta activity, presence of rapid eye movements, and nuchal EMG activity was used to identify areas most likely to be NREM, REM, or WAKE. REM sleep was identified as periods of low delta activity, an elevated ratio of theta/delta activity (TDratio), absent nuchal EMG activity, and the presence of rapid eye movements. NREM sleep was identified by evidence of increased delta activity, a low TDratio, intermediate nuchal EMG activity, and no rapid eye movements. The transition to WAKE was identified by a rapid increase in nuchal EMG activity and intermediate values for delta and the TDratio. An interactive program incorporating the digital video was then used to manually correct sleep-state transitions. Using this technique, ∼5% of the recording was left unscored.
For cardiorespiratory variables, the original digitized data were resampled at rates appropriate for the variable. For respiratory calculations, the maximum and minimum of each breath related pressure fluctuation were determined using an automated peak detector followed by manual correction, if necessary. The amplitude of each breath (maximum – minimum) was used to derive breath to breath tidal volume (VT) (Bartlett and Tenney, 1970). Minute ventilation (VE) was calculated as the product of VT and instantaneous respiratory rate (RR) calculated from the interbreath interval. The peak of each blood pressure pulse was determined similarly and was used to calculate beat-to-beat HR. BPm was calculated from the arterial pressure waveform.
For metabolic variables, body and plethysmograph temperature, inlet and outlet [O2] and [CO2], and plethysmograph gas flow rate were averaged in 1 s bins and smoothed using a 60 s time constant. VO2 was calculated from the difference in the fractional inlet and outlet [O2] and the gas flow rate. VCO2 was similarly calculated assuming an inlet room air fractional concentration of 0.0003. We made no attempt to correct the measurements for water content or the respiratory quotient (RQ) and assumed no major changes in either over the course of the experiments.
Neuroanatomy. At the conclusion of experiments, each piglet was killed with an injection of sodium pentobarbital followed by an intracardiac injection of 5–10 ml of saturated potassium chloride. Microinjections of 20–50 μl of 1% potassium permanganate were made through a broken microdialysis probe to mark the location of the tip of the microdialysis probe in reference to external landmarks (Sun et al., 2000). The brainstem was removed and frozen in cryoembedding medium (Tissue-Tek OCT; Sakura Finetek, Torrance, CA). Brainstems were cryosectioned (40 μm) at –18°C, and sections were thaw-mounted on gelatin-coated glass slides. Sections were fixed for 10 min in 37% phosphate-buffered formalin, pH 7.4, and then stained with cresyl violet.
The rostrocaudal length of the brainstem differed among piglets over the ages we studied, and coordinates expressed relative to the bregma or interaural line did not always accurately describe the location of dialysis probes with respect to internal medullary landmarks. Therefore, we expressed the location of each probe with respect to three relevant internal medullary structures: the midline, the ventral surface, and the caudal pole of the facial nucleus (Curran et al., 2001). For convenience, the lesions are plotted both in reference to the obex and the facial nucleus in the results section.
To determine the extent of the neuronal destruction caused by local dialysis of 5,7-DHT, immunohistochemical methods were used to identify neurons containing tryptophan hydroxylase (TPOH). TPOH immunohistochemistry in the piglet brainstem has been described in detail previously (Niblock et al., 2004). Adjacent sections were stained with cresyl violet for anatomical comparisons and identification of medullary nuclei and landmarks. In addition, neurons containing tyrosine hydroxylase (TyrOH) were also identified using an identical protocol, with the exception that monoclonal mouse anti-rat tyrosine hydroxylase antibody (Sigma) was used as the primary antibody.
To determine the extent of the destruction of 5-HT neurons in the PGCL, TPOH-immunoreactive (TPOH-ir) cells were counted on the lesioned side within a standardized counting area and compared with counts within an identical counting area on the unlesioned side. Rectangles of equal dimensions were superimposed onto each slice that was used for counting, on either side of the midline. The rectangle extended laterally from 1 to 4.2 mm lateral to the midline and from the ventral surface to 3.1 mm dorsal to the surface at the most medial dimension. Every sixth 40 μm section was counted, extending from 18 sections caudal to the end of the lesion to 18 sections rostral to the most rostral edge of the lesion. In a few instances, there were areas of tissue destruction within the counting area caused by the dialysis guide tube. To correct for this, the mirror image of the damaged area was superimposed on the unlesioned side, and cells within this area were excluded from the cell count. Cells were counted only if they were within the counting area, morphologically identifiable as neurons, axon and dendrite(s) were visible, and the neuronal cytoplasm had a dense distribution of reaction product that excluded the nucleus if visible.
To determine whether 5-HT1A receptors localize on 5-HT neurons in the PGCL, neurons were double labeled with antibodies for TPOH and the 5-HT1A receptor. Forty micrometer sections were fixed in 4% paraformaldehyde at 4°C for 30 min, blocked in 4% normal goat serum, and incubated in primary antibody overnight at 4°C. Sections were washed in PBS with 0.1% Triton-X and incubated in appropriate anti-rabbit and anti-mouse fluorescent secondary antibodies (Alexa Fluor) for 2 h at room temperature. Sections were then washed in PBS with 0.1% Triton-X and allowed to dry for 60 min at room temperature before being coverslipped in Fluoromount-G (Southern Biotechnology, Birmingham, AL).
Analysis and statistics. Twenty-one animals of either sex were studied on different days to determine the effects of 8-OH-DPAT on sleep. Time control experiments were performed on six animals, in which aCSF was dialyzed for the entire study period. Six experiments were performed with 10 mm 8-OH-DPAT, and 17 experiments were performed using 30 mm 8-OH-DPAT. An additional four animals were studied with both WAY100635 and 8-OH-DPAT, and the results were compared with both the six control and 17 30 mm 8-OH-DPAT experiments. Another four animals were studied with 30 mm 8-OH-DPAT 1 week after dialysis of 5,7-DHT. The results of these experiments were compared with a subgroup of piglets from the 30 mm 8-OH-DPAT experiments that were ≥12 d of age at the time they were studied.
Probe tips were considered to in the appropriate position if there was a high likelihood that dialyzed 8-OH-DPAT would extend into the PGCL. We therefore accepted probe tip locations that were at least 1 mm lateral to the midline and ≤1.5 mm lateral to the medial edge of the facial nucleus. For the analysis, we treated each study day as a separate case. Bout number, bout duration, and the percentage of time spent in each state was determined for REM, NREM, and WAKE, as well as slow wave or delta activity, integrated EEG amplitude, and integrated neck EMG activity. Data were averaged for the hour before and the hour starting with the onset of 8-OH-DPAT (or sham aCSF) dialysis and entered into a three-way ANOVA (Systat version 10.2; Systat, Evanston, IL). The dialysate (aCSF or 8-OH-DPAT) and the state (NREM, REM, WAKE) were considered repeated or within-subjects factors, and the 8-OH-DPAT dose (0, 10, or 30 mm) was used as a grouping factor. In some analyses, age or a combination of age and weight was added as covariates in the analysis. Post hoc tests were performed if there were significant interactions between factors. Pairwise comparisons were done by computing a critical T value from the MS error term (Winer, 1962) and correcting the resulting probability for multiple comparisons. Values were expressed as means ± SEM, and the criterion for statistical significance was set at p < 0.05.
Results
Distribution of 5-HT neurons in the piglet medulla and anatomic locations of dialysis probe tips
The distribution of TPOH-ir neurons in the piglet brainstem and its relationship to other species, including the human, has been described in detail previously (Niblock et al., 2004). In the piglet, the PGCL contains 5-HT neurons that lie in a column lateral to the midline that extends from the ponto-medullary border to several millimeters caudal to the caudal pole of the facial nucleus. The more rostral (juxtafacial) portion of the PGCL lies mostly medial to the facial nucleus. In the dorsoventral dimension, it extends from the midline to near the ventral surface. Figure 1A shows a three-dimensional (3-D) reconstruction of the piglet medulla showing the locations of TPOH-ir neurons (shown as red dots) in relation to the facial nucleus (shown in blue) and the approximate location and size of the distribution of dialyzed 8-OH-DPAT as determined by dialysis of 30 mm fluorescein (shown in yellow). The rationale for and problems associated with using fluorescein to determine distribution volume has been described previously (Curran et al., 2001). Nevertheless, the distribution of fluorescein provides a rough estimate of the extent of spread of dialyzed compounds of similar molecular weights. A 30 min dialysis of 30 mm fluorescein produced a 3-D ellipse that was ∼2.1 mm wide and ∼3.5 mm long with a volume of 13.2 μl. This value is approximately twice as large as the volumes obtained in our laboratory using 10 mm fluorescein dialyzed for 20 min in chronically instrumented piglets (5.8 μl) (Messier et al., 2002) or 10 min in decerebrate piglets (6.3 μl) (Curran et al., 2000). A typical section at the level of the facial nucleus is shown in Figure 1B, illustrating the location of TPOH-ir neurons.
Figure 2A shows the location of the dialysis probe tips in the study animals referenced to the obex, and Figure 2B shows the rostrocaudal and mediolateral position of the probe tips in relation to a standardized facial nucleus as discussed in Materials and Methods. Note that most of the tip locations are clustered medial to the facial nucleus.
Effect of 8-OH-DPAT on sleep architecture
Our initial analysis using 0 mm (time control; aCSF), 10 mm, and 30 mm 8-OH-DPAT revealed significant interactions between dose, state, age, and the effect of 8-OH-DPAT on several measures of sleep architecture, including bout number, bout duration, and time spent in each state. However, the effect of 10 mm 8-OH-DPAT was not consistently different from that of aCSF alone. In contrast, the effects of 30 mm 8-OH-DPAT on all variables were consistently different from both the effects of aCSF and 10 mm 8-OH-DPAT. We therefore elected to report in detail only the effects produced with 30 mm 8-OH-DPAT dialysis. Six animals were in the control group and received continuous dialysis with aCSF. They weighed 2.50 ± 0.27 kg and were 8.3 ± 1.5 d of age. In 17 experiments, animals were dialyzed with aCSF for ∼2 h and then were dialyzed with 30 mm 8-OH-DPAT for 30 min followed by aCSF dialysis for the remainder of the experiment. The animals in this group weighed 2.61 ± 0.12 kg and were 10.3 ± 0.8 d of age. There were no significant differences in the weights and ages of the two groups.
Because our studies were performed over an age range of 4–18 d, we first examined the relationship between age and measures of sleep architecture. Over the age range of the piglets that we studied, there was no relationship between age and bout number, bout duration, or the percentage of time spent in any state. However, the effect of 8-OH-DPAT on the bout numbers of NREM (R2 = 0.353; p = 0.012) and WAKE (R2 = 0.349; p = 0.013), but not REM, was progressively smaller with increasing age. In contrast, there was no relationship between age and the effect of 8-OH-DPAT on bout duration or percentage of time spent in any state. Age-related effects were taken into account in subsequent analyses when appropriate.
The main effect of dialyzing 8-OH-DPAT into the PGCL was fragmentation of sleep associated with a dramatic reduction in the amount of REM sleep. We defined sleep fragmentation as an increase in the number and a decrease in the duration of bouts of NREM sleep. Figure 3 shows data from a typical experiment. Note the regular cycling of sleep states before dialysis compared with the fragmented pattern during and shortly after 8-OH-DPAT dialysis. The most striking result was the marked decrease in the number of REM bouts and the percentage of time spent in REM after 8-OH-DPAT dialysis. REM was completely abolished in 53% (9 of 17) of the piglets. In the remaining eight piglets, there was a 75.4% decrease in the number of REM bouts. Figure 4 shows the effects of 8-OH-DPAT dialysis on bout number, bout duration, and the percentage of time spent in each state. Note the decrease in REM bouts associated with the increase in number of both NREM and WAKE bouts. In addition, bouts of NREM were shorter, resulting in no difference in the percentage of time spent in NREM. In contrast, bouts of WAKE were more frequent, but not of shorter duration, resulting in a significant increase in the percentage of time spent in WAKE.
In addition, the shorter periods of NREM were associated with lower levels of delta activity and integrated EEG amplitude after 8-OH-DPAT dialysis compared with continuous aCSF dialysis experiments. In addition, most animals exhibited a decrease in motor activity and a decrease in muscle tone during NREM after 8-OH-DPAT dialysis. Although an attempt was made to provide a thermoneutral environment, some animals exhibited shivering during NREM and WAKE during control periods, indicating that they were below their thermoneutral range. In these cases, there was a marked decrease or absence of shivering after 8-OH-DPAT dialysis. Neck EMG activity, on average, was also lower after 8-OH-DPAT dialysis. However, the small number of subjects accompanied by the large variation in the measurement of nEMG precluded a meaningful comparison between the changes in nEMG in the control (sham aCSF) group and the 8-OH-DPAT group. Mean and individual data are shown in Figure 5. Because of the possibility that periods that we scored as NREM after 8-OH-DPAT were examples of a dissociated state with REM-like hypotonia without rapid eye movements, we compared levels of neck EMG and EEG amplitude and δ activity during REM before 8-OH-DPAT with those during what we scored as NREM after 8-OH-DPAT. Although neck EMG amplitude, EEG amplitude, and δ activity were all lower during NREM after 8-OH-DPAT compared with control NREM values, they all remained considerably higher than during REM before 8-OH-DPAT (p < 0.03).
8-OH-DPAT and the 5-HT1A receptor
To confirm that the effects on sleep were secondary to activation of 5-HT1A receptors, we locally dialyzed WAY100635, a selective 5-HT1A receptor antagonist, into four animals before dialyzing 8-OH-DPAT. Figure 6 shows data from a single experiment. Note that sleep cycling is preserved during 8-OH-DPAT dialysis. The main effect of pretreatment with WAY100635, after taking age into account, was an inhibition of the effect of 8-OH-DPAT on REM bout number and percentage of time spent in REM. The ability of WAY100635 to prevent 8-OH-DPAT-induced changes in bout duration was less consistent. Figure 7 shows the group and individual data for bout number, comparing the WAY100635 data with both the control and 30 mm 8-OH-DPAT experiments. These data support the hypothesis that the effects of 8-OH-DPAT on sleep architecture are secondary to activation of 5-HT1A receptors.
We also hypothesized that the effects that we observed after 8-OH-DPAT dialysis were secondary to activation of 5-HT1A receptors located on 5-HT neurons and functioning as autoreceptors. Although it is widely accepted that 5-HT neurons located in the raphé colocalize with 5-HT1A receptors, there are no reports showing the presence of 5-HT1A receptors located on the somata or dendrites of 5-HT neurons in the PGCL. Although we did not do a quantitative analysis, we did confirm colocalization of TPOH-ir neurons and 5-HT1A receptors using immunohistochemistry. It was estimated that 90% of TPOH-ir neurons on each section also contained label for 5-HT1A receptors (D. S. Paterson, personal communication). The results from a representative section are shown in Figure 8. Examination of the distribution of the 5-HT1A receptor immunoreactivity suggests that 5-HT1A receptors are likely colocalized with both serotonergic and nonserotonergic neurons in the region of the PGCL that we studied.
To determine whether the effects that we observed were primarily secondary to activating autoreceptors, we unilaterally destroyed 5-HT neurons in the PGCL in four piglets by dialyzing 5,7-DHT, a selective toxin for 5-HT neurons, after pretreatment with desipramine to minimize destruction of any nearby TyrOH-containing neurons. After 1 week, 8-OH-DPAT was dialyzed into the regions, and the effects on sleep were evaluated and compared with the effects of 8-OH-DPAT dialysis in a subgroup of animals that were ≥12 d of age. Figure 9 illustrates the destruction of 5-HT neurons secondary to 5,7-DHT dialysis in one animal. Adjacent sections were stained with cresyl violet (Fig. 9A), for TPOH immunoreactivity (Fig. 9B), and for TyrOH immunoreactivity (Fig. 9C). Note the large area devoid of TPOH-ir neurons on the lesioned side (Fig. 9B). Also, there are very few TyrOH-immunoreactive (TyrOH-ir) neurons in this region, most lying more lateral to the rostral portion of the PGCL and importantly, as shown in Figure 9C, unaffected by 5,7-DHT. The cell counts are shown in Figure 10, showing the four individual piglets as well as the averaged data. The individual data show the location of the lesion in reference to the caudal pole of the facial nucleus, whereas the averaged data are referenced to the caudal edge of the lesion. The number of 5-HT neurons destroyed, expressed as a percentage of the control (nonlesioned) side, ranged from 39.7 to 77.5% and averaged 64.6 ± 8.7%.
By 1 week after 5,7-DHT dialysis, sleep was more fragmented compared with similar aged animals. There were more (p = 0.023) and shorter (p < 0.05) bouts of NREM per hour, with little or no change in the percentage of time spent in state. The bout number per hour, or bout duration of REM, was not different, and the percentage of time spent in REM was not affected. However, subsequent dialysis of 8-OH-DPAT did not decrease the amount of REM or change the relationship between the number, or duration, of bouts of WAKE or NREM, compared with a control group of similar ages (Fig. 11). Interestingly, the effect of 8-OH-DPAT on body temperature was not different in the animals treated with 5,7-DHT, compared with the control group of similar ages. Similarly, HR decreased after 8-OH-DPAT dialysis in the 5,7-DHT-treated animals similar to the changes in a similar-aged control group. These data indicate that the effects on sleep that we observed after 8-OH-DPAT dialysis were secondary to activation of somato-dendritic 5-HT1A autoreceptors. However, the effects of 8-OH-DPAT on body temperature and HR may have been secondary to stimulating postsynaptic 5-HT1A receptors located on nonserotonergic neurons that were involved in modulating these variables, perhaps by affecting sympathetic outflow.
Effect of 8-OH-DPAT on other physiological variables
CO2 concentration in the plethysmograph did not change over the course of the experiments and averaged ∼0.42–0.48%. Values for cardio-respiratory variables were related to age. Under control conditions, VE decreased with age during all states, primarily because of a decrease in RR with little or no change in VT. Heart rate, but not BPm, also decreased with age. Cardiorespiratory variables were modulated by state, confirming what we have reported previously (Darnall et al., 2001). Because of the marked decrease in the amount of REM after 8-OH-DPAT dialysis, we were not able to perform a complete analysis on the effects of 8-OH-DPAT dialysis. However, there were no consistent effects of 8-OH-DPAT dialysis on RR, VT, or VE during NREM or WAKE. In contrast, 8-OH-DPAT dialysis caused HR to decrease in 11 of 13 animals (p = 0.01). The mean decrease in HR was 7.7 ± 2.7 and 8.2 ± 2.9 beats/min for WAKE and NREM, respectively. Although there was a small increase in BPm in 10 of 13 animals, the overall effect was not significant (p = 0.07).
The wall temperature of the plethysmograph was adjusted in an attempt to achieve a thermoneutral environment based on weight and age. As a result, the air temperatures inside the plethysmograph varied with weight (p = 0.017), being lowest with the animals of greatest weight, but did not change over the course of the experiment (Table 1). Body temperature was related to both age and weight, and after taking this into account, body temperature fell after 8-OH-DPAT dialysis and was more pronounced in the younger animals (Table 1). Because of the gas flow dynamics of the plethysmograph, it was not possible to accurately measure changes in VO2, VCO2, and RQ across state changes. All states were therefore combined to assess the relationship to age and the effect of 8-OH-DPAT dialysis. VCO2 (p = 0.001; R2 = 0.24), but not VO2, decreased with increasing age resulting in a decreasing RQ (p = 0.044; R2 = 0.08). 8-OH-DPAT dialysis did not result in any consistent changes in VO2, VCO2, or RQ. The mean values for VO2, VCO2, and RQ before and after sham aCSF dialysis and before and after 8-OH-DPAT dialysis are shown in Table 1.
Discussion
The major findings are that dialyzing 8-OH-DPAT into the juxtafacial PGCL causes sleep fragmentation and a marked decrease in the amount of REM sleep. Although the rostral groups of 5-HT neurons play important roles in the regulation of sleep (Portas et al., 1996; Strecker et al., 1999; Monti et al., 2000; Sakai and Crochet, 2000; Sorensen et al., 2001), little is known about the role of 5-HT neurons in the PGCL in either regulating or modulating sleep. Large bilateral quisqualic acid lesions of the medial reticular formation encompassing the juxtafacial PGCL decrease the amount of REM (Holmes and Jones, 1994). Nonspecific neuronal inhibition with GABAA agonists (Curran et al., 2001; Darnall et al., 2001; Messier et al., 2002) or lidocaine (Berner et al., 1999) in this region decreases the amount of sleep and increases wakefulness. In studies focusing on the role of 5-HT neurons in the midline raphé and immediate adjacent areas, dialysis or microinjection of 8-OH-DPAT decreases sleep and increases wakefulness (Berner et al., 1999; Messier et al., 2004). We report the novel finding that 5-HT neurons in the juxtafacial PGCL play a role in the modulation of sleep and in particular, REM sleep. These findings suggest a possible link between sleep homeostasis and the abnormalities in serotonergic receptor binding found in a large subset of SIDS infants in two large independent data sets.
The sleep effects of 8-OH-DPAT dialysis into the PGCL are caused by activation of 5-HT1A somato-dendritic autoreceptors
It is likely that both somato-dendritic autoreceptors and postsynaptic 5-HT1A receptors located on non-5-HT neurons were activated by 8-OH-DPAT in our studies (Thor et al., 1992; Kia et al., 1996). However, the primary effects on sleep were caused by activation of 5-HT1A somato-dendritic autoreceptors. This conclusion is based on our results showing that (1) there are large numbers of 5-HT neurons located in the PGCL in the piglet (Niblock et al., 2004), (2) most of these (∼90%) colocalize with 5-HT1A receptors, (3) pretreatment with the selective 5-HT1A antagonist WAY100635 abolishes the sleep disrupting effects of subsequent 8-OH-DPAT dialysis, and (4) dialysis of 5,7-DHT into the PGCL produces sleep fragmentation similar to that produced with 8-OH-DPAT dialysis and eliminates the effect of subsequent 8-OH-DPAT dialysis on REM.
The effects of 8-OH-DPAT dialysis on body temperature and heart rate were likely attributable to the activation of postsynaptic 5-HT1A receptors. 5-HT1A receptors localize to nonserotonergic neurons in the raphé pallidus and parapyramidal region (Morrison, 2004) and in the rostral ventrolateral medulla (Holmes et al., 1994; Helke et al., 1997), where they are involved in thermoregulation and the control of blood pressure, respectively. Most of these neurons project to the intermediolateral column of the spinal cord and influence sympathetic activity involved in thermoregulation and cardiovascular control (Guyenet, 1990; Helke et al., 1997; Nakamura et al., 2004). Local application of 8-OH-DPAT into these regions, including the PGCL, in anesthetized animals consistently decreases blood pressure (Lovick, 1989; Helke et al., 1993). In contrast, we found in the conscious piglet that local dialysis of 8-OH-DPAT into the PGCL causes little or no change in blood pressure and a decrease in heart rate. These results are similar to those reported in two other studies in conscious animals in which 8-OH-DPAT was either dialyzed or microinjected into the caudal raphé and caused a decrease in heart rate with little or no change in blood pressure (Messier et al., 2004; Nalivaiko et al., 2005). Furthermore, destruction of 5-HT neurons with 5,7-DHT did not prevent the effects of subsequent 8-OH-DPAT dialysis on body temperature or heart rate, supporting the hypothesis that these effects were mediated by activation of postsynaptic 5-HT1A receptors located on nonserotonergic neurons.
Activation of 5-HT1A autoreceptors in the PGCL decreases the amount of REM sleep
A decrease in REM after 8-OH-DPAT dialysis in the PGCL was a consistent finding in all animals. Why does activation of 5-HT1A autoreceptors in this region of the brainstem decrease REM sleep? One possibility is that sleep fragmentation after 8-OH-DPAT dialysis prevented the development of REM (Benington and Heller, 1994; Borbely, 1994). However, destruction of 5-HT neurons with 5,7-DHT produced the same level of sleep fragmentation without affecting the amount of REM suggesting that these may be independent processes.
We postulate that the decrease in REM sleep after 8-OH-DPAT dialysis was secondary to the critical role played by 5-HT neurons in the PGCL in integrating multiple sensory inputs and modulating brain arousal and alerting systems. Neurons in the PGCL have major projections to the LC (Van Bockstaele and Aston-Jones, 1995), where there is a dense innervation of serotonergic fibers and terminals (Pickel et al., 1977). Serotonin attenuates excitatory amino acid responses of LC neurons (Aston-Jones et al., 1991b). The ventral oral pontine reticular nucleus, a region important for the generation and maintenance of REM sleep, receives abundant serotonergic innervation that is not from the dorsal or median raphé (Rodrigo-Angulo et al., 2000) and may include those from the PGCL. Thus, it is reasonable to hypothesize that withdrawal of serotonergic input to the LC and surrounding regions might interrupt the normal state related attenuation leading to alterations in REM sleep homeostasis.
Serotonergic neurons in the PGCL also have major projections to the dorsal horn of the spinal cord (Skagerberg and Bjorklund, 1985; Kwiat and Basbaum, 1992), where they modulate nociceptive (Basbaum and Fields, 1984; Leung and Mason, 1999) and non-nociceptive (Gray and Dostrovsky, 1983, 1985) sensory inputs. Furthermore, 5,6-DHT spinal cord lesions decrease REM in rats (Bjorkum et al., 1995), and intrathecal administration of 8-OH-DPAT increases the amount of sleep and decreases the amount of wakefulness (Bjorkum and Ursin, 1996). These data support the hypothesis that 5-HT neurons in the PGCL can modulate sleep state by dampening sensory input at the spinal cord level. Thus, inhibition of the activity of these neurons could result in an “undampening” of ascending sensory information promoting more wakefulness and the sleep fragmentation that we observed.
Dialysis of 8-OH-DPAT into the PGCL decreases muscle tone during NREM sleep
Skeletal muscle hypotonia during NREM similar to that seen during REM under control conditions was observed in some animals after 8-OH-DPAT dialysis. In a few animals, an attenuation in shivering during NREM was also observed, similar what occurs during REM under control conditions (Parmeggiani and Rabini, 1967). The classic studies by Magoun and Rhines suggested that neurons in the caudal medulla are involved in the modulation of muscle tone (Magoun, 1944; Magoun and Rhines, 1946). Neurons in PGCL project to thoracic, lumbar, and sacral segments of the spinal cord (Kausz, 1991) and have axon collateral projections to both autonomic and somatic cell groups (Allen and Cechetto, 1994). Spinally projecting glycinergic neurons that receive glutamatergic, cholinergic, and orexinergic inputs in this region have been implicated in the hypotonia associated with REM (Kodama et al., 1998; Lai et al., 1999; Hajnik et al., 2000; Mileykovskiy et al., 2002), and some appear to be serotonergic (Fort et al., 1993; Stornetta et al., 2004). It is possible that activation of either 5-HT1A somato-dendritic receptors on glycinergic/5-HT neurons or postsynaptic receptors located on non-5-HT glycinergic neurons might result in a change in muscle tone.
What we scored as short periods NREM after 8-OH-DPAT dialysis might represent a dissociated state with REM-like hypotonia. However, there were no rapid eye movements or REM-like changes in respiration, blood pressure, and heart rate. In addition, although the levels of δ power, EEG amplitude, and neck EMG activity were lower during NREM after 8-OH-DPAT dialysis, they were significantly higher than during REM bouts before 8-OH-DPAT. We therefore believe that the relative hypotonia after 8-OH-DPAT dialysis into the PGCL is more likely related to the role of 5-HT neurons of providing tonic state related motor facilitation important for the modulation of muscle tone and rhythmic motor activity (Jacobs and Fornal, 1999).
Implications for sudden infant death syndrome
Victims of sudden infant death syndrome presumably die during sleep. However, there has been little evidence to support a specific sleep abnormality. The focus of research has been on protective arousal mechanisms that help defend against stressors often encountered during sleep. However, an increase in arousability may not always be an advantage because it might lead to fragmented sleep and sleep deprivation. Prolonged deep periods of recovery sleep might also increase the risk of obstructive sleep apnea (Simpson, 2001). REM sleep deprivation in adult humans and animals has been found to cause many behavioral changes (Dement, 1960; Koller et al., 1969), and brief periods of sleep deprivation in infants alters the autonomic control of heart rate (Franco et al., 2003) and decrease arousals (Franco et al., 2004). Our new findings suggest that abnormalities in medullary serotonergic neurons produce sleep fragmentation and decreased amounts of REM sleep. 5-HT1A receptor activation in this study was restricted to a region where abnormal serotonergic receptor binding has been demonstrated in SIDS infants. More widespread serotonergic receptor dysfunction may lead to considerable alterations in sleep homeostasis, increasing the risk for sudden death.
Footnotes
This work was supported by National Institutes of Health Grants PO1 HD036379 and RO1 HD045653 and First Candle/SIDS Alliance Grant SP0030. We thank David S. Paterson for double labeling of TPOH and 5-HT1A receptors, Hannah C. Kinney for her support and research guidance, and Laurie Hildebrandt for her expert technical help.
Correspondence should be addressed to Dr. Robert A. Darnall, Department of Physiology, Borwell Building, 1 Medical Center Drive, Lebanon, NH 03756. E-mail: robert.a.darnall{at}hitchcock.org.
DOI:10.1523/JNEUROSCI.1770-05.2005
Copyright © 2005 Society for Neuroscience 0270-6474/05/258322-11$15.00/0